Clinical Trials Browser

OTHER × Brain Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT05638425 2022-12-06

Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung